Septerna raised $288 million in an IPO to support its drug development efforts.
Amount Raised
$288 Million
Round Type
IPO
San FranciscoBiotechnologyHealth CareScience And EngineeringDescription
Septerna, a San Francisco area drugmaker, recently went public and raised $288 million through its IPO. The company, alongside other biotech leaders, discussed the challenges of transitioning from private to public markets at a recent panel event.
Who else raised in Science And Engineering and Biotechnology around the same time
Companies in the same sectors as Septerna that raised within 45 days of this round, from Fundz verified event records.
- Wheeler Bio raised $35M (Series A) on March 20, 2025.
- Garuda Therapeutics raised $50M (Series A) on March 5, 2025.
- Wheeler Bio raised $23M on March 4, 2025.
- MAIA Biotechnology raised $4.1M (Seed) on February 18, 2025.
- NewcelX raised $2M (Seed) on March 28, 2025.
- OSSO raised $250K (Pre-Seed) on March 27, 2025.
Who to call at Septerna, and when
A new round usually means Septerna is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Septerna raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Septerna, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Septerna. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Septerna raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Septerna raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.